ABK Biomedical
ABK Biomedical raised US$55.5M in Series C funding.
Email and contact information
Company website: www.abkbiomedical.com/
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: Halifax, Nova Scotia (Canada)
Industry: Biotechnology, Health Care, Medical, Medical Device
Business model:
Funding
- Total funding amount: $55,460,149 (in USD)
- Estimated valuation: $277,300,745.00
- Latest deal type: Series C
- First fundind year: 2022
Growth
Founders: Bob Abraham, Daniel Boyd, Sharon Kehoe
Top investors: Innovacorp, F-Prime Capital, Varian, First Angel Network, Wilmington Investor Network
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK